The Company Reports Annual Revenue Growth of 6.3% and Annual Profit of $1.13 Million WESTBURY, NY–(Marketwired – Mar 30, 2015) – Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO) today reported its operating results for the three months and year ended December 31, 2014. “With a 6.3% year-over-year growth in annual revenue in 2014, we are pleased to...
Read More

Management to Hold Investor Conference Call on March 30, 2015 at 11:00 a.m. ET WESTBURY, NY / ACCESSWIRE / March 23, 2015 / Vasomedical, Inc. (OTCQB:VASO) announces today that it will release its financial results for the three months and year ended December 31, 2014 on Monday, March 30, 2015. The Company will host a...
Read More

WESTBURY, NY / ACCESSWIRE / January 7, 2015 / Vasomedical, Inc. (VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE...
Read More

WESTBURY, NY / ACCESSWIRE / November 13, 2014 / Vasomedical, Inc. (VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, today announced that, for the third consecutive year, it has been named on the Deloitte’s Technology Fast 500(TM) list, with a ranking of 166, up from 207 last...
Read More

WESTBURY... NY–(Marketwired – Nov 12... 2014) – Vasomedical... Inc. (“Vasomedical”) (OTCBB: VASO) today reported its operating results for the three months ended September 30... 2014. “We are pleased to report that during the third quarter of 2014 revenue from our Sales Representation segment increased 9.3% to $6.4 million compared to the same period in 2013...
Read More